tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market

CytoMed Therapeutics Limited (GDTC) Cash flow

6 Followers

CytoMed Therapeutics Limited Cash Flow

GDTC's free cash flow for Q was S$―. For the fiscal year, GDTC's free cash flow was decreased by S$-2.09M and operating cash flow was S$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21
Operating Cash Flow
-S$ -3.43MS$ -1.04MS$ -1.71M
Investing Cash Flow
-S$ -2.83MS$ -353.11KS$ -823.67K
Financing Cash Flow
-S$ 10.92MS$ 722.71KS$ 4.17M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
-S$ 6.22MS$ 1.84MS$ 2.51M
Income Tax Paid Supplemental Data
----
Interest Paid Supplemental Data
----
Issuance Of Capital Stock
-S$ 11.31MS$ 912.15KS$ 2.00M
Issuance Of Debt
-S$ -340.43KS$ -58.76KS$ 350.00K
Repayment Of Debt
-S$ -340.43KS$ -58.76KS$ -58.91K
Free Cash Flow
-S$ -3.49MS$ -1.40MS$ -2.30M
Domestic Sales
----
Foreign Sales
----
Currency in SGD

CytoMed Therapeutics Limited Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis